Doximity, Inc. (DOCS) Tops Q2 EPS by 5c, Beats on Revenue; Offers FY24 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. LEVI
2. NVDA
3. SBUX
4. SPY
5. GOOGL
6. APLD
7. USO
8. STZ
9. AGNT
10. ORCL

Go back to Doximity, Inc. (DOCS) Tops Q2 EPS by 5c, Beats on Revenue; Offers FY24 Guidance

Doximity Announces Fiscal 2024 Second Quarter Financial Results

November 9, 2023 4:01 PM EST

Total revenues of $113.6 million, up 11% year-over-year
Net income margin of 27% and adjusted EBITDA margin of 48%
Net income growth of 16% and adjusted EBITDA growth of 18% year-over-year

SAN FRANCISCO--(BUSINESS WIRE)-- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2024 second quarter ended September 30, 2023.

Were proud to make medicine mobile, with another quarter of record engagement across our entire platform, said Jeff Tangney, co-founder and CEO of Doximity. Over 550,000 unique providers used our generative AI,... More